← Evidence map

ReviewCurrent diabetes reviews2017

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials.

Matthew J LevinePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT06268977400 enrolled2024
Full record →Abstract, authors, funding and every citing paper · PMID 27296042